Why Peptides Could Become More Accessible in ...

How much AI spending is too much? And why are some Tesla and SpaceX investors losing patience with Elon Musk? Plus, why are Wall Street firms paying up to $100,000 for a fast track to Trump posts? Host Imani Moise discusses the biggest stock moves of the week and the news that dr ...  Show more

P.M. Edition for July 24. Today an FDA committee voted to increase access to six of seven peptides. Those are substances that haven’t undergone regulatory approval, but they’re promoted on social media and promise physical transformations like better skin. We hear from WSJ health ...  Show more

We start with details on an upcoming emergency hearing over the fallout from a controversial group chat that included a journalist. We’re hearing from three major US trading partners about President Trump’s auto tariffs. European leaders have stated their positions about whether ...  Show more

Investors are on edge as President Donald Trump’s new sweeping tariffs are set to go into effect this week. Elon Musk is expected to visit the CIA for the first time today. We have the latest on search and rescue efforts in Myanmar after a powerful earthquake last week. We’ll tel ...  Show more

Biden: "Can't let up" in fight against "dangerous" Delta variant. Dow sinks 725 points as Delta variant fears hit Wall Street. Two more U.S. athletes test positive ahead of Olympics. First Capitol riot felon sentenced, gets 8 month sentence for breaching Senate during January 6 a ...  Show more

How did the week’s AI dealmaking affect stocks? And why did President Trump’s comments on weight-loss drugs hurt pharma shares? Plus, how did the big six U.S. banks finish out the week after strong quarterly reports? Host Francesca Fontana discusses the biggest stock moves of the ...  Show more